1-3 of 3
Mina Khoshdeli
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Epcoritamab + R-mini-CHOP results in 2-year remissions and high MRD negativity rates in elderly patients with newly diagnosed DLBCL: Results from the EPCORE NHL-2 trial

Free
Chan Cheah, Juraj Ďuraš, David Belada, Justin Darrah, Yasmin Karimi, Franck Morschhauser, Gerardo Musuraca, Mats Hellstrom, Katerina Kopeckova, Lori Leslie, Anna Sureda Balarí, Catherine Thieblemont, Umberto Vitolo, Kojo Osei-Bonsu, Yi Hao, Monica Wielgos-Bonvallet, Mina Khoshdeli, Aidan Reilly, Malene Risum, Joost Vermaat, Joshua Brody
Journal: Blood
Blood (2025) 146 (Supplement 1): 64.
https://doi.org/10.1182/blood-2025-64
Published: 2025
Journal Articles

Fixed-duration epcoritamab + R-CHOP in patients with newly diagnosed DLBCL and high IPI scores (3–5) led to sustained remissions and disease-free survival beyond 3 years: Results from the EPCORE NHL-2 trial

Free
Lorenzo Falchi, Fritz Offner, Sven de Vos, Joshua Brody, Daniel Morillo, Kim Linton, Sylvia Snauwaert, Michael Roost Clausen, Raul Cordoba, Toshihiko Oki, Monica Wielgos-Bonvallet, Mina Khoshdeli, Yi Hao, Jennifer Marek, Malene Risum, David Belada
Journal: Blood
Blood (2025) 146 (Supplement 1): 1955.
https://doi.org/10.1182/blood-2025-1955
Published: 2025
Journal Articles

Epcore DLBCL-3 First Disclosure: Fixed-Duration Epcoritamab Monotherapy in Older (≥75 y), Anthracycline-Ineligible Patients with Previously Untreated Large B-Cell Lymphoma

Free
Franck Morschhauser, David Belada, Johannes Duell, Wojciech Jurczak, Tae Min Kim, Won Seog Kim, Takahiro Kumode, Javier López Jiménez, Caressa Meert, Sergio Ortegon Alcaide, Catherine Thieblemont, Yajian Jiang, Mina Khoshdeli, Yanli Wang, Evelyn Guo, Daniela Hoehn, Sherida Woei-A-Jin
Journal: Blood
Blood (2024) 144 (Supplement 1): 867.
https://doi.org/10.1182/blood-2024-199271
Published: 2024